This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Russia Viscosupplementation Market

Market Insights on Russia Viscosupplementation covering sales outlook, demand forecast & up-to-date key trends

Russia Viscosupplementation Market By Product Type (Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation), End Use (Hospitals, Ambulatory Surgical Centres, Orthopaedic Clinics) & Region - Forecast to 2016 - 2026

Single injection viscosupplementation segment is anticipated to record the highest CAGR during the projected period

The single injection viscosupplementation segment in the Russia viscosupplementation market is expected to expand at the fastest and highest CAGR of 6.0% over the forecast period, due to relatively less competition across the product type segments. The three injection viscosupplementation product type segment was estimated to account for more than 69.4% share of the Russia viscosupplementation market in 2016, which is projected to increase to over 68.8% by the end of 2026.

In Russia, three injection viscosupplementation is likely to be the highly preferred treatment of choice for osteoarthritis over the projected period and this is the precise reason that by the end of 2026, the three injection viscosupplementation product type segment is estimated to reach a market valuation in excess of US$ 23.5Mn. The three injection viscosupplementation product type segment is projected to be the most attractive segment in the Russia viscosupplementation market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Rising obesity and ageing population expected to drive the growth of the three injection viscosupplementation segment in Russia

Viscosupplemets are hyaluronic acid doses that are injected in the knee joints for the treatment of osteoarthritis (OA). The rising obesity rate, coupled with a rapidly increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. This factor is driving the growth of the single injection viscosupplementation segment in the Russia viscosupplementation market.

Increasing ageing population is another factor that is creating robust development in the Russia viscosupplementation market. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population in Russia and this is the precise reason for the rise in demand for three injection viscosupplementation.

Russia Viscosupplementation Market Download Report Brochure

Three injection viscosupplementation is a cost-effective procedure that reduces the cost burden of knee osteoarthritis patients. Several drugs for three injection viscosupplementation are in the pipeline and this is further creating a positive impact on this segment. Better patient compliance and reduction in the number of hospital visits is expected to drive the market growth of the three injection viscosupplementation segment over the forecast period.

Non-consideration of reimbursement by insurance companies in Russia is likely to be a hindrance to the growth in demand for three injection viscosupplementation

The cost of single injection viscosupplementation is lesser than three injection viscosupplementation. Besides, these three injections are available through online portals or can be procured directly from the pharmacists as well. However, several insurance companies and authorities do not consider these in the reimbursement list of products. Physicians have noted that the formulation of updated treatment guidelines by Osteoarthritis Research Society International (OARSI) for knee osteoarthritis has been restricting the overall outlook on viscosupplementation prescription.

This is expected to lead to increased insurance denials for three injection viscosupplementation. Three injection viscosupplementation is a lengthy procedure wherein patients suffering from osteoarthritis need to take three injections within the span of a certain time period. Owing to these restraints, single injections are expected to gain more popularity in Russia in the years to come.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Market share of companies operating in the Russia viscosupplementation market

The Russia viscosupplementation market is highly fragmented. Key players such as Hyaltech, Croma-Pharma GmbH and TRB Chemedica contribute around 65% of the market share. Hyaltech alone grabs more than 40% market share.

The market is divided into two segments based on product type and end use

By Product Type

  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation

By End Use

  • Hospitals
    • 500+ Bedded
    • 250-500 Bedded
    • Less Than 250 Bedded
  •  Ambulatory Surgical Centres
  • Orthopaedic Clinics
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Frequently Asked Questions

Demand for Russia viscosupplementation is likely to grow at a CAGR of 6.2% through 2032.

Sales of Russia viscosupplementation is likely to exceed a valuation of US$ 84.86 million by 2032.

Adoption of Russia viscosupplementation is likely to reach a valuation of US$ 46.5 million in 2022.

Rising obesity and ageing population are driving the growth of Russia viscosupplementation market.

Table of Content

1.  Executive Summary

2.  Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3.  Global Russia Viscosupplementation Market Analysis Scenario

3.1. Pricing Analysis and Projection

3.2. Market Size (US$ Mn) and Forecast , 2015-2026

3.2.1. Market Size and Y-o-Y Growth

3.2.2. Absolute $ Opportunity

3.3. Market Overview

3.3.1. Value Chain

4.  Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5. Forecast Factors – Relevance and Impact

4.6. Key Regulations

4.7. Pipeline Product Assessment

4.8. Pricing and Reimbursement Scenario

5. Russia Viscosupplementation Market Value and Volume Analysis  and Forecasts, By Product Type 

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Product Type 

5.3. Y-o-Y Growth Projections By Product Type 

5.4. Market Value Forecast By Product Type , 2016–2026

5.4.1. Single Injection Viscosupplementation

5.4.2. Three Injection Viscosupplementation

5.4.3. Five Injection Viscosupplementation

5.5. Prominent Trends

5.6. Market Attractiveness By Product Type 

6.  Russia Viscosupplementation Market Value and Volume Analysis and Forecasts, By End User 

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By End User 

6.3. Y-o-Y Growth Projections By End User 

6.4. Market Value Forecast By End User , 2016–2026

6.4.1. Hospitals 

6.4.1.1. 500+ Beds

6.4.1.2. 250-499 Beds

6.4.1.3. Less than 250 Beds

6.4.2. Ambulatory Surgical Centers

6.4.3. Orthopedic Clinics

6.5. Prominent Trends

6.6. Market Attractiveness By End User 

7. Competition Landscape

7.1.Competition Dashboard

7.2. Company Share Analysis (2015)

7.3.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

7.3.1. Anika Therapeutics Inc.

7.3.2. Bioventus LLC

7.3.3. Ferring B.V

7.3.4. Fidia Pharmaceutici S.p.A

7.3.5. MEDA Pharmaceuticals Switzerland GmbH

7.3.6. Sanofi S.A

7.3.7. ZIMMER BIOMET HOLDINGS, INC

8. Assumptions and Acronyms Used

9. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Russia Viscosupplementation Market Value (US$ Mn), by Product Type, 2015–2026

Table 2: Russia Viscosupplementation Market Volume (Units), by Product Type, 2015–2026

Table 3: Russia Viscosupplementation Market Value (US$ Mn), by End-use, 2015–2026

Table 4: Russia Viscosupplementation Market Volume (Units), by End-use, 2015–2026

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Russia Viscosupplementation Market Value Forecast (US$ Mn), 2016–2026

Figure 2: Russia Viscosupplementation Market Absolute $ Opportunity, 2016–2026

Figure 3: Russia Viscosupplementation Market Value Share, by Product Type, 2016 & 2026

Figure 4: Russia viscosupplementation  Y-o-Y Growth, by Product Type, 2016–2026

Figure 5: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Single Injection Viscosupplementation Product Type, 2015–2026

Figure 6: Russia Viscosupplementation Market Absolute $ Opportunity, by Single Injection Viscosupplementation Product Type, 2015–2026

Figure 7: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Three Injection Viscosupplementation Product Type, 2015–2026

Figure 8: Russia Viscosupplementation Market Absolute $ Opportunity, by Three Injection Viscosuplementation Product Type, 2015–2026

Figure 9: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Five Injection viscosupplementation Product Type, 2015–2026

Figure 10: Russia Viscosupplementation Market Absolute $ Opportunity, by Five Injection viscosupplementation Product Type, 2015–2026

Figure 11: Russia Viscosupplementation Market Attractiveness Analysis, by Product Type, 2015–2026

Figure 12: Russia Viscosupplementation Market Value Share, by End-use, 2016 & 2026

Figure 13: Russia Viscosupplementation Market Y-o-Y Growth Rate, by End-use, 2015–2026

Figure 14: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Hospitals End-use Segment, 2015–2026

Figure 15: Russia Viscosupplementation Market Absolute $ Opportunity, by Hospitals End-use Segment, 2015–2026

Figure 16: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Ambulatory Surgical Centres End-use Segment, 2015–2026

Figure 17: Russia Viscosupplementation Market Absolute $ Opportunity, by Ambulatory Surgical Centres End-use Segment, 2015–2026

Figure 18: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Orthopediac Clinics End-use Segment 2015–2026

Figure 19: Russia Viscosupplementation Market Absolute $ Opportunity, by Orthopediac Clinics End-use Segment, 2015–2026

Figure 20: Russia Viscosupplementation Market Attractiveness Analysis, by End-Use, 2015–2026

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Russia Viscosupplementation Market